Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes

OBJECT World Health Organization (WHO) Grade I (benign) meningiomas with atypical features may behave more aggressively than similarly graded tumors without atypical features. Here, the prognostic significance of atypical features in benign meningiomas was determined. METHODS Data from patients diag...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurosurgery 2016-01, Vol.124 (1), p.106-114
Hauptverfasser: Marciscano, Ariel E, Stemmer-Rachamimov, Anat O, Niemierko, Andrzej, Larvie, Mykol, Curry, William T, Barker, 2nd, Fred G, Martuza, Robert L, McGuone, Declan, Oh, Kevin S, Loeffler, Jay S, Shih, Helen A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 114
container_issue 1
container_start_page 106
container_title Journal of neurosurgery
container_volume 124
creator Marciscano, Ariel E
Stemmer-Rachamimov, Anat O
Niemierko, Andrzej
Larvie, Mykol
Curry, William T
Barker, 2nd, Fred G
Martuza, Robert L
McGuone, Declan
Oh, Kevin S
Loeffler, Jay S
Shih, Helen A
description OBJECT World Health Organization (WHO) Grade I (benign) meningiomas with atypical features may behave more aggressively than similarly graded tumors without atypical features. Here, the prognostic significance of atypical features in benign meningiomas was determined. METHODS Data from patients diagnosed with WHO Grade I benign meningiomas per the 2007 WHO criteria and who underwent surgery between 2002 and 2012 were retrospectively reviewed. Patients were stratified by the absence or presence of 1 to 2 atypical features with review of the clinical and histological factors. RESULTS A total of 148 patients met the inclusion criteria (n = 77 with atypia; n = 71 without atypia). The median follow-up duration after pathological diagnosis was 37.5 months. Thirty patients had progression/recurrence (P/R) after initial treatment, and 22 (73%) of 30 patients with P/R had 1-2 atypical features. The presence of atypical features was significantly associated with P/R (p = 0.03) and independent of the MIB-1 labeling index. The 1-year and 5-year actuarial rates of P/R were 9.6% versus 1.4% and 30.8% versus 13.8% fortumors with and without atypical features, respectively. Higher Simpson grade resection (II-IV vs I) was associated with the increased risk of P/R (p < 0.001). Stratification of patients into low-risk (Simpson Grade I), intermediate-risk (Simpson Grade II-IV with no atypical features), and high-risk groups (Simpson Grade II-IV with atypical features) was significantly correlated with increased risk of P/R (p < 0.001). CONCLUSIONS Patients with benign meningiomas with atypical features and those undergoing Simpson Grade II-IV resection are at significantly increased risk of P/R. Patients with these features may benefit from the consideration of additional surgery and/or radiation therapy.
doi_str_mv 10.3171/2015.1.JNS142228
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1753007165</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1753007165</sourcerecordid><originalsourceid>FETCH-LOGICAL-c388t-b5797ccfb297c506410ca729910c18a9adb4874449e595d3e6021ae4f80259f53</originalsourceid><addsrcrecordid>eNplkD1PwzAQhi0EoqWwMyGPZUg5fyUxGyBoiyo6AGKMXNdpjZK42I4Qf4DfTb9gYXp1p-de6R6EzgkMGMnIFQUiBmTw-PRMOKU0P0BdIhlLIJXsEHUBKE0Y5KKDTkJ4ByApT-kx6tCUZlxK0kXft6axiwbX62gW1tUq4P7baIqHXs0NHl_iTxuXWMWvldWqwksboqvcYjuURsXWm3CNtfPeVCpa12BX7qiVist_6K5OV7bZrl0btatNOEVHpaqCOdtnD70-3L_cjZLJdDi-u5kkmuV5TGYik5nW5YyuQ0DKCWiV0fUnoEmupJrPeJ5xzqURUsyZSYESZXiZAxWyFKyH-rvelXcfrQmxqG3QpqpUY1wbCpIJBpCRdIPCDtXeheBNWay8rZX_KggUG_vFxn5Bij_765OLfXs7q8387-BXN_sBz12Bjw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1753007165</pqid></control><display><type>article</type><title>Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Marciscano, Ariel E ; Stemmer-Rachamimov, Anat O ; Niemierko, Andrzej ; Larvie, Mykol ; Curry, William T ; Barker, 2nd, Fred G ; Martuza, Robert L ; McGuone, Declan ; Oh, Kevin S ; Loeffler, Jay S ; Shih, Helen A</creator><creatorcontrib>Marciscano, Ariel E ; Stemmer-Rachamimov, Anat O ; Niemierko, Andrzej ; Larvie, Mykol ; Curry, William T ; Barker, 2nd, Fred G ; Martuza, Robert L ; McGuone, Declan ; Oh, Kevin S ; Loeffler, Jay S ; Shih, Helen A</creatorcontrib><description>OBJECT World Health Organization (WHO) Grade I (benign) meningiomas with atypical features may behave more aggressively than similarly graded tumors without atypical features. Here, the prognostic significance of atypical features in benign meningiomas was determined. METHODS Data from patients diagnosed with WHO Grade I benign meningiomas per the 2007 WHO criteria and who underwent surgery between 2002 and 2012 were retrospectively reviewed. Patients were stratified by the absence or presence of 1 to 2 atypical features with review of the clinical and histological factors. RESULTS A total of 148 patients met the inclusion criteria (n = 77 with atypia; n = 71 without atypia). The median follow-up duration after pathological diagnosis was 37.5 months. Thirty patients had progression/recurrence (P/R) after initial treatment, and 22 (73%) of 30 patients with P/R had 1-2 atypical features. The presence of atypical features was significantly associated with P/R (p = 0.03) and independent of the MIB-1 labeling index. The 1-year and 5-year actuarial rates of P/R were 9.6% versus 1.4% and 30.8% versus 13.8% fortumors with and without atypical features, respectively. Higher Simpson grade resection (II-IV vs I) was associated with the increased risk of P/R (p &lt; 0.001). Stratification of patients into low-risk (Simpson Grade I), intermediate-risk (Simpson Grade II-IV with no atypical features), and high-risk groups (Simpson Grade II-IV with atypical features) was significantly correlated with increased risk of P/R (p &lt; 0.001). CONCLUSIONS Patients with benign meningiomas with atypical features and those undergoing Simpson Grade II-IV resection are at significantly increased risk of P/R. Patients with these features may benefit from the consideration of additional surgery and/or radiation therapy.</description><identifier>ISSN: 0022-3085</identifier><identifier>EISSN: 1933-0693</identifier><identifier>DOI: 10.3171/2015.1.JNS142228</identifier><identifier>PMID: 26274991</identifier><language>eng</language><publisher>United States</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Combined Modality Therapy ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Ki-67 Antigen ; Male ; Meningioma - pathology ; Meningioma - surgery ; Meningioma - therapy ; Middle Aged ; Neoplasm Recurrence, Local - epidemiology ; Neurosurgical Procedures ; Prognosis ; Radiotherapy, Adjuvant ; Retrospective Studies ; Risk Assessment ; Treatment Outcome ; World Health Organization ; Young Adult</subject><ispartof>Journal of neurosurgery, 2016-01, Vol.124 (1), p.106-114</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c388t-b5797ccfb297c506410ca729910c18a9adb4874449e595d3e6021ae4f80259f53</citedby><cites>FETCH-LOGICAL-c388t-b5797ccfb297c506410ca729910c18a9adb4874449e595d3e6021ae4f80259f53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26274991$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marciscano, Ariel E</creatorcontrib><creatorcontrib>Stemmer-Rachamimov, Anat O</creatorcontrib><creatorcontrib>Niemierko, Andrzej</creatorcontrib><creatorcontrib>Larvie, Mykol</creatorcontrib><creatorcontrib>Curry, William T</creatorcontrib><creatorcontrib>Barker, 2nd, Fred G</creatorcontrib><creatorcontrib>Martuza, Robert L</creatorcontrib><creatorcontrib>McGuone, Declan</creatorcontrib><creatorcontrib>Oh, Kevin S</creatorcontrib><creatorcontrib>Loeffler, Jay S</creatorcontrib><creatorcontrib>Shih, Helen A</creatorcontrib><title>Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes</title><title>Journal of neurosurgery</title><addtitle>J Neurosurg</addtitle><description>OBJECT World Health Organization (WHO) Grade I (benign) meningiomas with atypical features may behave more aggressively than similarly graded tumors without atypical features. Here, the prognostic significance of atypical features in benign meningiomas was determined. METHODS Data from patients diagnosed with WHO Grade I benign meningiomas per the 2007 WHO criteria and who underwent surgery between 2002 and 2012 were retrospectively reviewed. Patients were stratified by the absence or presence of 1 to 2 atypical features with review of the clinical and histological factors. RESULTS A total of 148 patients met the inclusion criteria (n = 77 with atypia; n = 71 without atypia). The median follow-up duration after pathological diagnosis was 37.5 months. Thirty patients had progression/recurrence (P/R) after initial treatment, and 22 (73%) of 30 patients with P/R had 1-2 atypical features. The presence of atypical features was significantly associated with P/R (p = 0.03) and independent of the MIB-1 labeling index. The 1-year and 5-year actuarial rates of P/R were 9.6% versus 1.4% and 30.8% versus 13.8% fortumors with and without atypical features, respectively. Higher Simpson grade resection (II-IV vs I) was associated with the increased risk of P/R (p &lt; 0.001). Stratification of patients into low-risk (Simpson Grade I), intermediate-risk (Simpson Grade II-IV with no atypical features), and high-risk groups (Simpson Grade II-IV with atypical features) was significantly correlated with increased risk of P/R (p &lt; 0.001). CONCLUSIONS Patients with benign meningiomas with atypical features and those undergoing Simpson Grade II-IV resection are at significantly increased risk of P/R. Patients with these features may benefit from the consideration of additional surgery and/or radiation therapy.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Combined Modality Therapy</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Ki-67 Antigen</subject><subject>Male</subject><subject>Meningioma - pathology</subject><subject>Meningioma - surgery</subject><subject>Meningioma - therapy</subject><subject>Middle Aged</subject><subject>Neoplasm Recurrence, Local - epidemiology</subject><subject>Neurosurgical Procedures</subject><subject>Prognosis</subject><subject>Radiotherapy, Adjuvant</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Treatment Outcome</subject><subject>World Health Organization</subject><subject>Young Adult</subject><issn>0022-3085</issn><issn>1933-0693</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkD1PwzAQhi0EoqWwMyGPZUg5fyUxGyBoiyo6AGKMXNdpjZK42I4Qf4DfTb9gYXp1p-de6R6EzgkMGMnIFQUiBmTw-PRMOKU0P0BdIhlLIJXsEHUBKE0Y5KKDTkJ4ByApT-kx6tCUZlxK0kXft6axiwbX62gW1tUq4P7baIqHXs0NHl_iTxuXWMWvldWqwksboqvcYjuURsXWm3CNtfPeVCpa12BX7qiVist_6K5OV7bZrl0btatNOEVHpaqCOdtnD70-3L_cjZLJdDi-u5kkmuV5TGYik5nW5YyuQ0DKCWiV0fUnoEmupJrPeJ5xzqURUsyZSYESZXiZAxWyFKyH-rvelXcfrQmxqG3QpqpUY1wbCpIJBpCRdIPCDtXeheBNWay8rZX_KggUG_vFxn5Bij_765OLfXs7q8387-BXN_sBz12Bjw</recordid><startdate>201601</startdate><enddate>201601</enddate><creator>Marciscano, Ariel E</creator><creator>Stemmer-Rachamimov, Anat O</creator><creator>Niemierko, Andrzej</creator><creator>Larvie, Mykol</creator><creator>Curry, William T</creator><creator>Barker, 2nd, Fred G</creator><creator>Martuza, Robert L</creator><creator>McGuone, Declan</creator><creator>Oh, Kevin S</creator><creator>Loeffler, Jay S</creator><creator>Shih, Helen A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201601</creationdate><title>Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes</title><author>Marciscano, Ariel E ; Stemmer-Rachamimov, Anat O ; Niemierko, Andrzej ; Larvie, Mykol ; Curry, William T ; Barker, 2nd, Fred G ; Martuza, Robert L ; McGuone, Declan ; Oh, Kevin S ; Loeffler, Jay S ; Shih, Helen A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c388t-b5797ccfb297c506410ca729910c18a9adb4874449e595d3e6021ae4f80259f53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Combined Modality Therapy</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Ki-67 Antigen</topic><topic>Male</topic><topic>Meningioma - pathology</topic><topic>Meningioma - surgery</topic><topic>Meningioma - therapy</topic><topic>Middle Aged</topic><topic>Neoplasm Recurrence, Local - epidemiology</topic><topic>Neurosurgical Procedures</topic><topic>Prognosis</topic><topic>Radiotherapy, Adjuvant</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Treatment Outcome</topic><topic>World Health Organization</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marciscano, Ariel E</creatorcontrib><creatorcontrib>Stemmer-Rachamimov, Anat O</creatorcontrib><creatorcontrib>Niemierko, Andrzej</creatorcontrib><creatorcontrib>Larvie, Mykol</creatorcontrib><creatorcontrib>Curry, William T</creatorcontrib><creatorcontrib>Barker, 2nd, Fred G</creatorcontrib><creatorcontrib>Martuza, Robert L</creatorcontrib><creatorcontrib>McGuone, Declan</creatorcontrib><creatorcontrib>Oh, Kevin S</creatorcontrib><creatorcontrib>Loeffler, Jay S</creatorcontrib><creatorcontrib>Shih, Helen A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neurosurgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marciscano, Ariel E</au><au>Stemmer-Rachamimov, Anat O</au><au>Niemierko, Andrzej</au><au>Larvie, Mykol</au><au>Curry, William T</au><au>Barker, 2nd, Fred G</au><au>Martuza, Robert L</au><au>McGuone, Declan</au><au>Oh, Kevin S</au><au>Loeffler, Jay S</au><au>Shih, Helen A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes</atitle><jtitle>Journal of neurosurgery</jtitle><addtitle>J Neurosurg</addtitle><date>2016-01</date><risdate>2016</risdate><volume>124</volume><issue>1</issue><spage>106</spage><epage>114</epage><pages>106-114</pages><issn>0022-3085</issn><eissn>1933-0693</eissn><abstract>OBJECT World Health Organization (WHO) Grade I (benign) meningiomas with atypical features may behave more aggressively than similarly graded tumors without atypical features. Here, the prognostic significance of atypical features in benign meningiomas was determined. METHODS Data from patients diagnosed with WHO Grade I benign meningiomas per the 2007 WHO criteria and who underwent surgery between 2002 and 2012 were retrospectively reviewed. Patients were stratified by the absence or presence of 1 to 2 atypical features with review of the clinical and histological factors. RESULTS A total of 148 patients met the inclusion criteria (n = 77 with atypia; n = 71 without atypia). The median follow-up duration after pathological diagnosis was 37.5 months. Thirty patients had progression/recurrence (P/R) after initial treatment, and 22 (73%) of 30 patients with P/R had 1-2 atypical features. The presence of atypical features was significantly associated with P/R (p = 0.03) and independent of the MIB-1 labeling index. The 1-year and 5-year actuarial rates of P/R were 9.6% versus 1.4% and 30.8% versus 13.8% fortumors with and without atypical features, respectively. Higher Simpson grade resection (II-IV vs I) was associated with the increased risk of P/R (p &lt; 0.001). Stratification of patients into low-risk (Simpson Grade I), intermediate-risk (Simpson Grade II-IV with no atypical features), and high-risk groups (Simpson Grade II-IV with atypical features) was significantly correlated with increased risk of P/R (p &lt; 0.001). CONCLUSIONS Patients with benign meningiomas with atypical features and those undergoing Simpson Grade II-IV resection are at significantly increased risk of P/R. Patients with these features may benefit from the consideration of additional surgery and/or radiation therapy.</abstract><cop>United States</cop><pmid>26274991</pmid><doi>10.3171/2015.1.JNS142228</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3085
ispartof Journal of neurosurgery, 2016-01, Vol.124 (1), p.106-114
issn 0022-3085
1933-0693
language eng
recordid cdi_proquest_miscellaneous_1753007165
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adolescent
Adult
Aged
Aged, 80 and over
Combined Modality Therapy
Disease Progression
Female
Follow-Up Studies
Humans
Ki-67 Antigen
Male
Meningioma - pathology
Meningioma - surgery
Meningioma - therapy
Middle Aged
Neoplasm Recurrence, Local - epidemiology
Neurosurgical Procedures
Prognosis
Radiotherapy, Adjuvant
Retrospective Studies
Risk Assessment
Treatment Outcome
World Health Organization
Young Adult
title Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T09%3A35%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Benign%20meningiomas%20(WHO%20Grade%20I)%20with%20atypical%20histological%20features:%20correlation%20of%20histopathological%20features%20with%20clinical%20outcomes&rft.jtitle=Journal%20of%20neurosurgery&rft.au=Marciscano,%20Ariel%20E&rft.date=2016-01&rft.volume=124&rft.issue=1&rft.spage=106&rft.epage=114&rft.pages=106-114&rft.issn=0022-3085&rft.eissn=1933-0693&rft_id=info:doi/10.3171/2015.1.JNS142228&rft_dat=%3Cproquest_cross%3E1753007165%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1753007165&rft_id=info:pmid/26274991&rfr_iscdi=true